Ignite Creation Date:
2025-12-24 @ 2:05 PM
Ignite Modification Date:
2025-12-30 @ 11:58 PM
Study NCT ID:
NCT04729595
Status:
TERMINATED
Last Update Posted:
2022-12-06
First Post:
2021-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients.
Sponsor:
Adamis Pharmaceuticals Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-21
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-25
First Submit QC Date:
None
Study First Post Date:
2021-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-05
Last Update Post Date:
2022-12-06
Last Update Post Date Type:
ACTUAL